FindTrial
Sign In

Role of insulin in wound healing

Efficacy of Short acting vs Long acting Insulin in Split Thickness Skin Graft donor site wound healing - A Comparative Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107371
Enrollment
30
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T818- Other complications of procedures,not elsewhere classified Health Condition 2: L98- Other disorders of skin and subcutaneous tissue, not elsewhere classified

Interventions

Intervention1: Nil: Nil

Sponsors

Sanjay Gandhi Post Graduate Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 and 65 years old nondiabetic individuals where a large intermediate thickness skin graft will be required (Graft size not less than 15x5cm).

Exclusion criteria

Exclusion criteria: (i) Patients under 18 years of age and above 65 years of age (ii) History of cardiovascular diseases (iii) Pregnancy (iv) Hepatic and renal disease (v) Immunocompromised patients (vi) Allergic to insulin

Design outcomes

Primary

MeasureTime frame
compare the efficacy of subdermally injected short vs Long acting insulin in intermediate thickness split thickness skin graft donor sites wound healingTimepoint: 21 days—

Secondary

MeasureTime frame
NILTimepoint: 21 days—

Countries

India

Contacts

Public ContactRAJIV KUMAR BHARTI

Sanjay Gandhi Post Graduate Institute of Medical Sciences

rajivbharti01@gmail.com9621900192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026